Plasma Kallikrein Inhibitor
- Name
- Plasma Kallikrein Inhibitor
- Accession Number
- DBCAT003454
- Description
Not Available
- Drugs
Drug Drug Description Ecallantide A kallikrein inhibitor used to prevent and treat acute attacks caused by Hereditary Angioedema (HAE). Berotralstat An inhibitor of plasma kallikrein used for prophylaxis of angioedema attacks in patients with hereditary angioedema. Lanadelumab A monoclonal antibody targeted against kallikrein which is used to treat attacks of hereditary angioedema. - Drugs & Drug Targets
Drug Target Type Ecallantide Plasma kallikrein target Berotralstat Cytochrome P450 2D6 enzyme Berotralstat Cytochrome P450 3A4 enzyme Berotralstat P-glycoprotein 1 transporter Berotralstat ATP-binding cassette sub-family G member 2 transporter Berotralstat Plasma kallikrein target Lanadelumab Plasma kallikrein target